Angola has taken a monumental step forward in safeguarding its future generations by officially adopting the National Immunization Strategy (NIS) 2026-2030. This bold move underscores the nation's unwavering dedication to child health and the enhancement of its Expanded Program on Immunization. But here's where it gets even more impactful: the NIS isn't just a plan—it's a comprehensive roadmap with clear priorities and ambitious goals, meticulously aligned with the World Health Organization (WHO) guidelines and global immunization benchmarks.
Crafted through a collaborative, evidence-based process, the NIS places equity, sustainability, and integrated vaccination services at the heart of Angola's public health mission. And this is the part most people miss: the WHO wasn't just a bystander—they played a pivotal role, offering technical expertise from the initial situational analysis to the final review of the monitoring framework.
Dr. Sílvia Lutucuta, Angola's Minister of Health, poignantly remarked, “The National Immunization Strategy 2026-2030 arrives at a historic moment as Angola celebrates 50 years of independence. For our government and partners, protecting every Angolan child is not just a duty—it’s an investment in our nation’s future.”
The Strategy sets its sights on transformative targets: achieving 90% vaccination coverage by 2030, slashing the number of zero-dose children to under 5%, maintaining a polio-free status, eradicating neonatal tetanus, and meeting measles elimination goals. To make this vision a reality, the NIS focuses on strengthening the cold chain, securing sustainable financing, training healthcare workers, and bolstering epidemiological surveillance and outbreak response.
Dr. Helga Freitas, National Director of Public Health, emphasized, “This Strategy will be a game-changer, ensuring Angola makes steady progress in child protection, integrates vaccination into primary healthcare, and fortifies its response to vaccine-preventable diseases.”
Recent milestones, such as the introduction of the HPV vaccine for over 2.2 million girls, highlight Angola's relentless pursuit of disease prevention and improved vaccination coverage. Yet, the success of the NIS hinges on collaboration. The Ministry of Health, WHO, UNICEF, the World Bank, Rotary International, and other partners are uniting to expand immunization efforts, train professionals, update technical standards, and introduce cutting-edge vaccine storage technologies.
Dr. Indrajit Hazarika, WHO Representative in Angola, praised the NIS as “a robust framework aligned with global best practices. WHO remains committed to supporting Angola in ensuring every child, in every province, has access to life-saving vaccines.”
But here’s the controversial question: Can Angola truly achieve these ambitious targets in the face of resource constraints and logistical challenges? While the Strategy is comprehensive, its success will depend on sustained funding, political will, and community engagement. What do you think? Is Angola on the right track, or are there critical areas that need more attention? Share your thoughts in the comments—let’s spark a conversation about the future of global health!
